Peptide questions · Linaclotide
Linaclotide side effects: what studies and users report
Reviewed Evidence: EstablishedPublished by PepVault
The side effects most commonly reported for linaclotide are diarrhea, abdominal pain and gas, among 5 the library lists; the library’s evidence on it includes controlled trials in people.
Its safety note opens: The Linzess label carries a boxed warning for children under 2: in newborn mice a single adult-sized dose caused deaths from dehydration, so it is never given under age 2.
What is commonly reported with linaclotide
- Diarrhea
- Abdominal pain
- Gas
- Bloating
- Headache
Common here means the library lists it among the effects people most often report; the list doesn’t say how often each one happens.
| Effect | Also listed for (of 18) |
|---|---|
| Diarrhea | None: listed for Linaclotide alone |
| Abdominal pain | None: listed for Linaclotide alone |
| Gas | None: listed for Linaclotide alone |
| Bloating | None: listed for Linaclotide alone |
| Headache | 6: TB-500, Thymosin Beta-4, VIP, ARA-290 and 2 more |

Which linaclotide side effects the healing & recovery group shares
Across the 19 healing & recovery compounds in the library, the effects listed most often are headache (7 of 19), injection site reaction (7 of 19), nausea (rare) (7 of 19) and fatigue (6 of 19). Linaclotide shares 1 of its 5 listed effects with at least one other healing & recovery compound; diarrhea, abdominal pain, gas and bloating are listed for linaclotide alone.
What the linaclotide safety notes say
The library’s safety note
The Linzess label carries a boxed warning for children under 2: in newborn mice a single adult-sized dose caused deaths from dehydration, so it is never given under age 2. In adults the main risk is diarrhea: 16 to 22% in its trials, severe in about 2% on 145 or 290 mcg, mostly starting in the first 2 weeks; after approval, severe diarrhea with dizziness, fainting, low blood pressure or low potassium or sodium has needed hospital care, and the label suspends dosing and rehydrates when it happens. It is not used with a known or suspected bowel blockage. Allergic reactions, including anaphylaxis, and rectal bleeding have been reported after approval. These are label findings; review them with your clinician.
The library’s interaction note
The label lists no drug interactions: linaclotide and its active metabolite stay below detection in the blood, and it is broken down inside the gut. Taken right after a high-fat breakfast it gave looser, more frequent stools than on an empty stomach. Diarrhea from it can add to dehydration from other causes, such as a GLP-1's vomiting. Discuss all your medicines with your clinician.
These are reference notes from published research and reported use, not advice for a person: discuss your own situation with your clinician.
Where the linaclotide reports come from
The library rates the evidence on linaclotide as established: clinical trials or FDA-approved use exist.
Of the library’s 5 research notes on linaclotide, 3 rest on randomized trials, 1 on clinical data and 1 on community reports.
Our 8 study pages on linaclotide: 3 meta-analyses, 4 randomized trials and 1 clinical trial.
So linaclotide has controlled trials in people to set its listed effects against.
What our linaclotide study pages report on safety
Linaclotide plus PEG improved colonoscopy prep quality in 8 RCTs
Meta-analysis, human, 2026: It also lowered adverse events. This pooled evidence suggests linaclotide added to PEG gives a cleaner bowel prep with fewer adverse events, but it did not find more adenomas or polyps overall.
Linaclotide plus 1 L PEG-Asc: 92% vs 86% adequate prep vs senna
Randomized trial, human, 2025: Side effects were similar between the groups, and most people said they would take the same prep again (83% vs 81%, P = 0.49). In a large trial, adding linaclotide to a 1 L colonoscopy prep cleaned the bowel better than adding senna, mainly in people at high risk of a poor prep, with similar side effects.
Linaclotide: bowel prep scores similar to double-dose PEG
Meta-analysis, human, 2025: The linaclotide groups had less nausea, vomiting, abdominal pain and bloating and were more willing to repeat the colonoscopy. In pooled studies, linaclotide with PEG cleaned the bowel about as well as double the PEG dose, with fewer stomach side effects.
Linaclotide raised weekly bowel movements in kids with constipation
Randomized trial, human, 2024: Diarrhea was the most common side effect on linaclotide, in 4% of children vs 2% on placebo. A 17-year-old girl on linaclotide had severe diarrhea that led to dehydration and a hospital stay, and it cleared up after IV fluids; no one died.
Linaclotide: trend to more bowel movements in kids at higher doses
Randomized trial, human, 2024: Diarrhea was the most common side effect, mostly mild and never severe. In children with functional constipation, linaclotide was well tolerated over 4 weeks, with higher doses showing a trend toward more bowel movements.
Linaclotide beat placebo for chronic constipation in 12-week trials
Randomized trial, human, 2011: Side effects were similar across groups except diarrhea, which made 4.2% of patients in both linaclotide arms stop treatment. In two large placebo-controlled trials, linaclotide helped more people with chronic constipation reach regular bowel movements over 12 weeks, with diarrhea as the side effect that stood out.
Questions people ask
What are the side effects of linaclotide?
The side effects most commonly reported for linaclotide are diarrhea, abdominal pain and gas, among 5 the library lists; the library’s evidence on it includes controlled trials in people.
Do linaclotide’s side effects come from human studies?
The library rates the evidence on linaclotide as established, and the library’s evidence on it includes controlled trials in people.
Which linaclotide side effects are its own?
Among the healing & recovery compounds, the library lists diarrhea, abdominal pain, gas and bloating for linaclotide alone.
Does linaclotide interact with other medicines?
The library’s interaction note on linaclotide begins: The label lists no drug interactions: linaclotide and its active metabolite stay below detection in the blood, and it is broken down inside the gut.